Case Study
Solutions for Life Sciences
OM1 combines cutting-edge technology, extensive data and industry-leading experience to reduce research costs, strengthen regulatory submissions and commitments, and drive adoption.
How We Help Life Sciences
R&D
Accelerate discovery and development.
Understand disease phenotypes and subtypes, disease progression, and treatment response in clinical real-world data, enriched with AI and extensively linked to other data types.
Plan studies better with robust RWD and event prediction. Recruit faster with patient and site level real-world data and AI tools.
Reduce costs and improve results by reducing manual effort and improving long-term follow-up with agentic data automation, decentralized procedures and linkage to additional data sources.
Strengthen submissions with ECAs, regulatory-ready RWE, registries and long-term follow-up studies that support substantial evidence for launch, label expansion and post-market commitments.
Safety
Monitor and demonstrate safety outcomes with regulatory confidence.
Conduct post-approval safety studies (PASS), long-term follow-up (LTFU), roll-over studies and registries with agentic automation and linkage, reducing cost and burden.
Leverage AI innovation to better predict and manage safety events.
Harness cost-effective tools built specifically for LTFU for cell and gene therapy and rare disease programs.
Medical Affairs
Elevate medical strategy with evidence that matters.
Leverage automation and experience with 300+ registries and post-approval studies to build programs with lower costs and proven higher site satisfaction.
Use AI phenotypes to find patients with unrecognized or progressive diseases and to educate providers.
Improve diagnosis, identify care gaps and predict outcomes through point of care tools.
Access or generate enriched clinical data for post-market evidence and publications.
HEOR
Demonstrate value with robust real-world insights.
Access enriched clinical RWD—including EHR, labs, PROs, unstructured notes, SDOH and linked claims—to generate credible insights.
Leverage AI and clinically rich data to evaluate outcomes, burden, and treatment effectiveness in real-world use.
Analyze resource utilization and comparators with expert methodologies for payer-ready evidence.
Quantify disease burden and unmet need to inform coverage, pricing, and value-based strategies.
Commercial
Drive precision engagement and adoption.
Accelerate diagnosis and treatment with AI patient-finding tools, enabling the right information to reach providers and patients.
Prioritize outreach with AI, identifying providers most able to take meaningful action but who are invisible to traditional lists.
Reduce uptake barriers by uncovering why patients start, stop, or switch therapies.
Evidence in Action
Life Sciences Case Studies from OM1
Case Study
Case Study
Our Solutions
Built on our award-winning AI platform, OM1 solutions redefine how real-world evidence is generated, shared, and applied.
Patient Finding and Outcomes Prediction
PhenOM® is OM1’s healthcare foundation model, trained on over 1 billion patient-years. It powers digital phenotyping and medical event prediction that accelerates diagnoses, uncovers subtypes, estimates treatment effects and forecasts outcomes for individuals and populations.
Clinical Registries and Automated Studies
OM1 brings unmatched experience and automation to registries and observational studies, reducing burden for sites and patients while generating regulatory-ready evidence that’s fit for purpose, scalable, and cost-effective.
Clinical Datasets and
Insights
Access curated datasets and OM1's Real-World Data Cloud, covering 350M+ patients with linked, longitudinal data from EMR, claims, and specialty networks. License cohorts, analyze real-world outcomes, and generate insights that drive decision-making.
Scientific and Consulting Services
Work with OM1’s experts in data science, epidemiology, AI and regulatory strategy to design and execute fit-for-purpose programs, align evidence with requirements, and maximize the value of AI and real-world data.
Let’s Talk About Your Goals
From research and evidence to predictive insights and beyond.